Home » Topics » BioWorld Science

BioWorld Science
RSS

Casma Therapeutics launched to develop breakthrough therapies by boosting autophagy

May 4, 2018

DLK inhibitor shows promising data in vivo

May 4, 2018

First patient dosed in phase II study of AG-10 in ATTR cardiomyopathy

May 4, 2018

Altum Pharmaceuticals acquires Lexi Pharma

May 4, 2018

FDA approves AndexXa to reverse factor Xa inhibitors

May 4, 2018

New albumin-binding compounds from CytRx show antitumor activity in xenograft models

May 4, 2018

Moderna Therapeutics and Merck & Co. expand cancer collaboration

May 4, 2018

FDA joint advisory committee meeting recommends against stannsoporfin

May 4, 2018

Phase I trial begins of CS-1002 for advanced solid tumors begins in Australia

May 4, 2018

Dong-A Socio Holdings identifies Mer inhibitors

May 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...